Coronavirus briefs
A non-peer-reviewed study suggested that the Astra-Zeneca-Oxford vaccine can reduce transmissions by two-thirds. Meanwhile, the European Medicines Agency approved the AZ jab for everyone over 18. But officials in France, Germany and Sweden are recommending that it not be offered to over 65s, and in Poland to over 60s, believing there is insufficient data to say it is effective in those age groups. Switzerland refused to license it at all. Johnson & Johnson reported that its new single-jab vaccine was 66% effective overall in preventing covid-19, and that protection increases over time. As with other vaccines, J&J’s trials showed its jab has lower efficacy in South Africa, where a particularly pernicious strain of covid-19 has been observed. A peer-reviewed analysis in the Lancet of Russia’s Sputnik V vaccine showed it had an…